Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Biofeedback de la variabilité de la fréquence cardiaque dans les forces de sécurité (GNR-HRVB)

2 novembre 2026 mis à jour par: Egas Moniz - Cooperativa de Ensino Superior, CRL

Biofeedback de la Variabilité de la Fréquence Cardiaque dans la Régulation de la Détresse et la Prévention de l'Épuisement Professionnel Chez les Forces de Sécurité

This exploratory study evaluates the effectiveness of a 12-session Heart Rate Variability Biofeedback (HRV-BFB) protocol in reducing distress and burnout while promoting psychological well-being among Portuguese National Republican Guard (GNR) professionals. Exposed to high occupational stress from unpredictable risks, shift work, and limited resources, these individuals face elevated vulnerability to chronic stress outcomes. The intervention leverages real-time HRV feedback to enhance autonomic regulation, breathing techniques, and emotional self-regulation.

Aperçu de l'étude

Description détaillée

Security forces like the GNR play a critical role in public safety but endure chronic stress from violence exposure, rapid decisions, shift rotations, and institutional resource shortages, heightening risks of distress, burnout, and impaired well-being. Distress arises when perceived threats exceed coping resources, leading to persistent negative emotions and health disruptions. Burnout manifests as exhaustion, mental distancing, and reduced efficacy from unmanaged chronic stress, with organizational impacts including absenteeism and eroded public trust. Psychological well-being encompasses multidimensional aspects like autonomy, relationships, and purpose beyond mere absence of illness. Traditional interventions face barriers such as stigma and access issues in rural GNR contexts, necessitating flexible, self-administered tools.

Intervention: HRV-BFB Protocol HRV-BFB trains participants to consciously modulate physiological responses via real-time monitoring of heart rate variability (HRV), reflecting sympathetic-parasympathetic balance. Low HRV links to mental health risks, while training targets resonance frequency breathing (~6 breaths/min or 0.1 Hz) to boost HRV amplitude, cardiac coherence, and baroreflex strength. Delivered autonomously via app post-initial guidance, the 12-session protocol requires no daily clinician oversight, enhancing accessibility for dispersed GNR personnel. Evidence shows HRV-BFB reduces stress, anxiety, depression, and burnout while fostering well-being in high-stress groups like emergency workers.

Study Objectives This exploratory trial tests whether HRV-BFB significantly lowers distress (multidimensional: physical, cognitive, emotional, behavioral), burnout levels, and boosts psychological well-being in GNR professionals. It aims to inform scalable interventions tailored to Portuguese police realities, addressing gaps in institutional support.

Type d'étude

Interventionnel

Inscription (Réel)

38

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Setúbal, Le Portugal
        • GNR - Comando Terrritorial de Setúbal (GNR - Setubal Territorial Command Centre)

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 55 ans (Adulte)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  1. Operational military personnel of the Guarda Nacional Republicana (GNR) performing security, patrol, criminal investigation, or road safety duties
  2. Any military rank or professional category within operational roles
  3. Age between 18 and 55 years, inclusive
  4. Both males and females
  5. Capable of providing informed consent in Portuguese language

Exclusion Criteria:

  1. Extended sick leave or medical absence
  2. Currently involved in serious disciplinary proceedings
  3. Use, modification, or initiation of psychotropic medication (including antidepressants, anti-anxiety medications, antipsychotics, mood stabilizers) within the past 6 months

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: HRV Biofeedback Training

Participants receive 12 individual sessions of heart rate variability biofeedback (HRV-BFB) over 4 weeks (one 12-minute session every 2 days). Training is delivered using a chest-worn ECG sensor (eSense Pulse) connected to a mobile application that provides real-time visual feedback.

Participants receive a structured heart rate variability biofeedback (HRV-BFB) training protocol delivered over 4 weeks. The intervention uses a portable chest-worn ECG sensor (eSense Pulse) connected via Bluetooth to a mobile application that provides real-time visual feedback of heart rate variability. Each participant completes 12 individual sessions of 12 minutes each (one session every 2 days). Sessions take place in a quiet room and follow a standardized format: a brief preparation phase, followed by approximately 10 minutes of guided breathing at resonance frequency (around 6 breaths per minute) using a visual breathing guide. The application displays color-coded feedback indicating how closely the participant's physiological response matches the target HRV pattern, and participants are instructed to adjust their breathing and recall positive memories to maximize time in the desired state. The aim is to increase HRV, strengthen parasympathetic activation, and improve stress and

Autres noms:
  • Biofeedback VRC
  • Formation à la respiration à fréquence de résonance
Aucune intervention: Control: No Intervention

Participants receive no active intervention during the 4-week study intervention period and continue their usual duties and routines. They complete the same assessment schedule as the experimental group at baseline, 4 weeks, and 10 weeks. After completion of the final follow-up assessment, they are offered the opportunity to receive the HRV biofeedback training protocol.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Change in Psychological Distress (Kessler Psychological Distress Scale - K10)
Délai: Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)

The Kessler Psychological Distress Scale (K-10) is a 10-item self-report measure assessing psychological distress over the past 30 days. Items measure anxiety and depressive symptoms on a 5-point Likert scale (1=never to 5=always). Total score range: 10-50 (higher scores indicate greater distress). Portuguese validation: α=0.91. Primary outcome is change from baseline to post-intervention (week 4) and follow-up (week 10).

Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)
Change in Occupational Burnout (Burnout Assessment Tool - BAT-12)
Délai: Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)

The Burnout Assessment Tool Short Form (BAT-12) is a 12-item self-report measure of occupational burnout across 4 dimensions: exhaustion (3 items), mental distance (3 items), cognitive impairment (3 items), emotional impairment (3 items). 5-point Likert scale (1=never to 5=always). Total score range: 12-60. Portuguese validation: α=0.85. Primary outcome is change from baseline to post-intervention and follow-up.

Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)
Change in Psychological Well-Being (WHO-5 Well-Being Index)
Délai: Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)

The WHO-5 Well-Being Index is a 5-item self-report measure of psychological well-being over the past 2 weeks. Items assess positive mood, vitality, sleep, daily functioning, and life satisfaction on a 0-5 scale. Total score range: 0-25 (higher=higher well-being). Primary outcome is change from baseline to post-intervention and follow-up.

Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
SDNN (Standard Deviation of NN Intervals) - Heart Rate Variability
Délai: Baseline (Week 0), after each of 12 training sessions

SDNN measures the standard deviation of the average NN (R-R) intervals in milliseconds during a recording period. It is a general indicator of overall heart rate variability and reflects the body's overall capacity for physiological adaptation and autonomic flexibility. Higher SDNN values indicate better autonomic regulation.

Baseline (Week 0), after each of 12 training sessions
RMSSD (Root Mean Square of Successive Differences) - Parasympathetic Activity
Délai: Baseline (Week 0), after each of 12 training sessions

RMSSD measures the root mean square of successive differences between adjacent NN (R-R) intervals in milliseconds. It is a primary time-domain measure of high-frequency heart rate variability and specifically reflects parasympathetic (vagal) nervous system activity and the body's recovery capacity. Higher RMSSD indicates stronger parasympathetic tone.

Baseline (Week 0), after each of 12 training sessions
Stress Index - Autonomic Balance Indicator
Délai: Baseline (Week 0), after each of 12 training sessions

The Stress Index is a proprietary metric derived from heart rate variability analysis that quantifies autonomic nervous system balance. Lower values indicate better autonomic regulation and lower physiological stress levels. Higher values reflect sympathetic dominance and poorer stress adaptation.

Baseline (Week 0), after each of 12 training sessions

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

28 janvier 2026

Achèvement primaire (Réel)

20 septembre 2026

Achèvement de l'étude (Réel)

20 septembre 2026

Dates d'inscription aux études

Première soumission

28 janvier 2026

Première soumission répondant aux critères de contrôle qualité

28 janvier 2026

Première publication (Réel)

4 février 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

3 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

2 novembre 2026

Dernière vérification

1 janvier 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

INDÉCIS

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner